BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12861027)

  • 1. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.
    Yamamoto K; Ishiai M; Matsushita N; Arakawa H; Lamerdin JE; Buerstedde JM; Tanimoto M; Harada M; Thompson LH; Takata M
    Mol Cell Biol; 2003 Aug; 23(15):5421-30. PubMed ID: 12861027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to mitomycin C requires direct interaction between the Fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain.
    Kruyt FA; Abou-Zahr F; Mok H; Youssoufian H
    J Biol Chem; 1999 Nov; 274(48):34212-8. PubMed ID: 10567393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
    Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
    Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
    Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
    DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
    Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
    J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.
    Wilson JB; Blom E; Cunningham R; Xiao Y; Kupfer GM; Jones NJ
    Mutat Res; 2010 Jul; 689(1-2):12-20. PubMed ID: 20450923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient regulation of DNA double-strand break repair in Fanconi anemia fibroblasts.
    Donahue SL; Lundberg R; Saplis R; Campbell C
    J Biol Chem; 2003 Aug; 278(32):29487-95. PubMed ID: 12748186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice.
    Koomen M; Cheng NC; van de Vrugt HJ; Godthelp BC; van der Valk MA; Oostra AB; Zdzienicka MZ; Joenje H; Arwert F
    Hum Mol Genet; 2002 Feb; 11(3):273-81. PubMed ID: 11823446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination.
    Yamamoto K; Hirano S; Ishiai M; Morishima K; Kitao H; Namikoshi K; Kimura M; Matsushita N; Arakawa H; Buerstedde JM; Komatsu K; Thompson LH; Takata M
    Mol Cell Biol; 2005 Jan; 25(1):34-43. PubMed ID: 15601828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.
    Kuang Y; Garcia-Higuera I; Moran A; Mondoux M; Digweed M; D'Andrea AD
    Blood; 2000 Sep; 96(5):1625-32. PubMed ID: 10961856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins.
    Park SJ; Ciccone SL; Beck BD; Hwang B; Freie B; Clapp DW; Lee SH
    J Biol Chem; 2004 Jul; 279(29):30053-9. PubMed ID: 15138265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
    Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
    DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage.
    Futaki M; Igarashi T; Watanabe S; Kajigaya S; Tatsuguchi A; Wang J; Liu JM
    Carcinogenesis; 2002 Jan; 23(1):67-72. PubMed ID: 11756225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant.
    Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH
    DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.
    Garcia-Higuera I; Kuang Y; Denham J; D'Andrea AD
    Blood; 2000 Nov; 96(9):3224-30. PubMed ID: 11050007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K63-linked ubiquitination of FANCG is required for its association with the Rap80-BRCA1 complex to modulate homologous recombination repair of DNA interstand crosslinks.
    Zhu B; Yan K; Li L; Lin M; Zhang S; He Q; Zheng D; Yang H; Shao G
    Oncogene; 2015 May; 34(22):2867-78. PubMed ID: 25132264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
    van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
    Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.